A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Condition: SmallpoxInterventions: Biological: IMVAMUNE; Biological: IMVAMUNESponsor: Bavarian NordicCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2009 Category: Research Source Type: clinical trials
Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)
Conditions: Smallpox; Atopic DermatitisIntervention: Biological: MVA (smallpox vaccine)Sponsors: Sanofi; Sanofi Pasteur, a Sanofi CompanyWithdrawn - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2006 Category: Research Source Type: clinical trials